Rivaroxaban axapharm 15 mg, Filmtabletten - 98 Swissmedic Key 69420006 Registration Holder axapharm ag Name Rivaroxaban axapharm 15 mg, Filmtabletten Date of registration 20.12.2024 Original/Generic Generic Introduction of Sequence 20.12.2024 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until 19.12.2029 Index Therapeuticus (BSV) 06.03.40. Show package size 98 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 62.10 Limitation Yes Limitation text
Deductible 10 % Consumer price 84.40 Feedback FB Daily cost GTIN 7680694200066 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 15 mg, cellulosum microcristallinum, lactosum monohydricum 21.58 mg, natrii laurilsulfas, hypromellosum, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 3350, E 172 (rubrum), pro compresso obducto corresp. natrium max. 0.25 mg. Packungsbestandteile Galenic Form Filmtabletten Active Agent Dose Rivaroxabanum 15 mg
BAG: Active Agent Dose Rivaroxabanum 15 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Überzug Lactose Monohydrat 21.58 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Pro Compresso Obducto
Source Data was imported : 07.01.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
